FI972054A - Immunogeenisiä koostumuksia - Google Patents

Immunogeenisiä koostumuksia Download PDF

Info

Publication number
FI972054A
FI972054A FI972054A FI972054A FI972054A FI 972054 A FI972054 A FI 972054A FI 972054 A FI972054 A FI 972054A FI 972054 A FI972054 A FI 972054A FI 972054 A FI972054 A FI 972054A
Authority
FI
Finland
Prior art keywords
immunogenic compositions
immunogenic composition
solubilised
immunogen
absence
Prior art date
Application number
FI972054A
Other languages
English (en)
Swedish (sv)
Other versions
FI972054A0 (fi
Inventor
Roger Randal Charles New
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of FI972054A publication Critical patent/FI972054A/fi
Publication of FI972054A0 publication Critical patent/FI972054A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI972054A 1994-11-15 1997-05-14 Immunogeenisiä koostumuksia FI972054A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions
PCT/GB1995/002675 WO1996014871A1 (en) 1994-11-15 1995-11-14 Immunogenic compositions

Publications (2)

Publication Number Publication Date
FI972054A true FI972054A (fi) 1997-05-14
FI972054A0 FI972054A0 (fi) 1997-05-14

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972054A FI972054A0 (fi) 1994-11-15 1997-05-14 Immunogeenisiä koostumuksia

Country Status (19)

Country Link
EP (1) EP0792165B1 (fi)
JP (1) JP4297515B2 (fi)
KR (1) KR970706848A (fi)
CN (1) CN100346828C (fi)
AT (1) ATE249841T1 (fi)
AU (1) AU700910B2 (fi)
CA (1) CA2205083A1 (fi)
DE (1) DE69531793T2 (fi)
DK (1) DK0792165T3 (fi)
ES (1) ES2210318T3 (fi)
FI (1) FI972054A0 (fi)
GB (1) GB9422990D0 (fi)
IL (1) IL116010A0 (fi)
MX (1) MX9703480A (fi)
NO (1) NO972219L (fi)
NZ (1) NZ295238A (fi)
PT (1) PT792165E (fi)
WO (1) WO1996014871A1 (fi)
ZA (1) ZA959729B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
UY25089A1 (es) * 1997-07-10 2000-08-21 Hoechst Roussel Vet Gmbh Vacunas no acuosas
ATE275421T1 (de) * 1998-02-12 2004-09-15 Wyeth Corp Interleukin-12 und herpes simplex virusantigen enthaltende impfstoffe
IL137809A0 (en) * 1998-02-12 2001-10-31 American Cyanamid Co Pneumococcal and meningococcal vaccines formulated with interleukin-12
EP1053016A2 (en) * 1998-02-12 2000-11-22 American Cyanamid Company Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
US6630161B1 (en) * 1998-05-07 2003-10-07 Ribi Immunochem Research, Inc. Adjuvant composition and methods for its use
CN1230184C (zh) 1998-07-16 2005-12-07 东市郎 以细菌的菌体成分为有效成分的癌免疫治疗用制剂
WO2009039628A1 (en) 2007-09-27 2009-04-02 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
BRPI0817484B1 (pt) * 2007-10-03 2021-08-17 Immunovaccine Technologies Inc Composição de vacina sem água, processo de produção e o uso dos mesmos
JP5715051B2 (ja) 2008-06-05 2015-05-07 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． リポソーム、抗原、ポリヌクレオチド及び疎水性物質の連続相を含む担体を含む組成物
EP2654782A4 (en) * 2010-12-23 2015-03-25 Immport Therapeutics Inc PROCESSES AND COMPOSITIONS FROM PROTEIN ANTIGEN FOR THE DIAGNOSIS AND TREATMENT OF TOXOPLASMA GONDII INFECTIONS AND TOXOPLASMOSIS
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
JP6240077B2 (ja) 2011-10-06 2017-11-29 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． Ｔｌｒ２を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
WO1993000069A1 (en) * 1991-06-26 1993-01-07 Brocades Pharma B.V. Vesicles in non-polar media
JPH09501169A (ja) * 1993-08-06 1997-02-04 オパーバス ホールディング ビー ヴィ 小胞に生体高分子物質を高度に充填する方法
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
DE69531793T2 (de) 2004-07-15
JP4297515B2 (ja) 2009-07-15
KR970706848A (ko) 1997-12-01
CN100346828C (zh) 2007-11-07
DE69531793D1 (de) 2003-10-23
EP0792165B1 (en) 2003-09-17
MX9703480A (es) 1997-08-30
FI972054A0 (fi) 1997-05-14
GB9422990D0 (en) 1995-01-04
JPH10508834A (ja) 1998-09-02
NZ295238A (en) 1999-01-28
CA2205083A1 (en) 1996-05-23
IL116010A0 (en) 1996-01-31
ATE249841T1 (de) 2003-10-15
PT792165E (pt) 2004-02-27
WO1996014871A1 (en) 1996-05-23
EP0792165A1 (en) 1997-09-03
CN1163575A (zh) 1997-10-29
NO972219D0 (no) 1997-05-14
AU700910B2 (en) 1999-01-14
NO972219L (no) 1997-07-11
AU3853495A (en) 1996-06-06
ZA959729B (en) 1997-05-15
DK0792165T3 (da) 2004-01-05
ES2210318T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
FI972054A (fi) Immunogeenisiä koostumuksia
IT1229845B (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
WO1997001640A3 (en) Vaccines against hepatitis c
DK1382348T3 (da) Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
AU4622693A (en) Potentiation of immunogenic response
NO911949D0 (no) Tgf-beta-preparater.
DZ2283A1 (fr) Composition de vaccin.
NO894588L (no) Kosmetisk fremstilling som inneholder chitosan.
DK0939648T3 (da) Rotavirusvaccineformuleringer
IL98262A (en) Chromone derivatives and pharmaceutical compositions containing them
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
DK150604C (da) Analogifremgangsmaade til fremstilling af calciumoxaprozin
DE69431662D1 (de) Stabilisierte tablettenformulierung
AU7528087A (en) Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it
CA2078985A1 (fr) Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
DE3767940D1 (de) Pyranderivate.
MX9204323A (es) Procedimiento para la preparacion de derivados de taxano.
IT1294969B1 (it) Composizione immunogena per hiv
SE8503513D0 (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.